PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $798,000 | -60.7% | 10,459 | -63.9% | 0.01% | -52.9% |
| Q1 2021 | $2,032,000 | +17.1% | 29,000 | 0.0% | 0.02% | +30.8% |
| Q4 2020 | $1,735,000 | +275.5% | 29,000 | +208.5% | 0.01% | +160.0% |
| Q3 2018 | $462,000 | +0.2% | 9,400 | -34.7% | 0.01% | -16.7% |
| Q2 2018 | $461,000 | -52.9% | 14,400 | -54.1% | 0.01% | -53.8% |
| Q1 2018 | $978,000 | +155.4% | 31,400 | +273.8% | 0.01% | +225.0% |
| Q4 2017 | $383,000 | -52.5% | 8,400 | -66.4% | 0.00% | -60.0% |
| Q4 2016 | $807,000 | – | 25,000 | +49900.0% | 0.01% | – |
| Q3 2013 | $0 | -100.0% | 50 | 0.0% | 0.00% | -100.0% |
| Q2 2013 | $21,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |